STAT Plus: Pharmalittle: India to ramp up ingredients production; CIA warns employees about taking hydroxycholoroquine
Rise and shine, everyone, another challenging day is on the way. We can tell because our short person is up early for another day of online learning, such as it is, and the official mascot is running about in search of tasty things to chew. As for us, we are resorting to our usual habit of brewing cups of stimulation — our choice today is glazed doughnut — and, as always, we invite you to join us. Remember, no prescription is required. Meanwhile, here are some tidbits to help you along. Stay in touch and stay safe.
India plans to ramp up production of pharmaceutical ingredients and become an alternative supplier for global drug makers hit by factory shutdowns in China due to the coronavirus outbreak, Bloomberg News says. The Indian government has aggressively begun implementing a policy to ramp up local output and emerge as an alternate to China. The “China-plus one” strategy involves identifying essential drug ingredients, providing incentives to domestic manufacturers, and reviving ailing state-run drug makers.
Continue to STAT Plus to read the full story…
